Forces International

Back to The evidence

STUDIES IMPLICATE HPV IN BLADDER CANCER,
HPV MAY BE KEY TO "EXCESS SMOKING RISK"

 

Return to FORCES International main page

Back to main page

4-8-98

  Human papillomavirus and bladder cancer. Lopez-Beltran A, Escudero AL. Biomed & Pharmacother 1997;51(6-7):252-257.
 
  Disregard the lead statement of this report that "human papillomavirus (HPVs) have not been proven to exhibit a causative role in human cancers,..." This statement is now false, since both the IARC and NIH have declared HPV to be a cause of cancer in humans.

   
With state of the art detection techniques, HPV is now found in nearly 100% of cervical cancers. HPV infection is more common among smokers due to riskier sexual behavior, which resulted in confounding in older studies that falsely implicated smoking.
 
Human papillomaviruses were originally known merely as the cause of genital warts, a venereal disease. Now, studies of the role of HPV in cancer of organs other than the anogenital region are appearing. More than 27 studies of the role of HPV in bladder cancer are reviewed in this work.
 
"...Studies from the general population showed a variable incidence of high risk HPV DNA which ranged from 2.5% to 81%, with HPV 16 DNA occurring more frequently. HPV was detected in both papillary and invasive cancers, although in our experience the overall incidence was low.... In addition, molecular studies suggest that the HPV related oncoproteins E6 and E7 play a role in bladder carcinogenesism via inactivation and/or degradation of p53 and pRb suppressor gene-associated proteins."
 
Overexpression of the p53 suppressor gene is the most common event in bladder cancer. Mutagens from cigarette smoke have been claimed to cause this; however, this is what the E6 and E7 oncoproteins of HPV do.
 
HPV may be the key to part or all of the supposed smoking-related risk of bladder cancer, just as it was the key to the false smoking risk of cervical cancer. The relative risk for cervical cancer in the CDC's SAMMEC is around 2, similar to the relative risk for bladder cancer of 2.5 to 3 (Shultz et al. Public Health Reports 1991 May-Jun;106(3):326-333).
 
There is now no excuse for the health establishment to trumpet studies of smoking and bladder cancer which lack the HPV risk factor. If they do so, they are committing a scientific fraud, and deceiving the public about the risks of smoking.
 
To date, there have evidently been no epidemiological studies examining HPV as a risk factor, as opposed to laboratory and clinical outcome studies such as these. Also, the health establishment has a record of refusing to be forthright on the question of "How much of the ostensible smoking risk is actually due to confounding by the other risk factor?"  Concealing this type of data is reprehensible.


 Courtesy of Carol Thompson
Smokers' Rights Action Group
P.O. Box 259575
Madison, WI 53725-9575
Phone: 608-249-4568